LiSyM Pillar II: Chronic Liver Disease Progression (LiSyM-DP) (Fraunhofer Institute for Medical Image Computing (MEVIS)) ; LiSyM network (Fraunhofer Institute for Medical Image Computing (MEVIS)) ; LiSyM Scientific Leadership Team (LiSyM-LT) (Fraunhofer Institute for Medical Image Computing (MEVIS)) ; LiSyM-Krebs Partnering (Fraunhofer Institute for Medical Image Computing (MEVIS))
In one in five people with NAFLD, the functioning liver cells, the hepatocytes, are replaced by connective tissue. Eventually this fibrosis becomes irreversible. In this state the liver is like a ‘scar that never heals’. Through it, the liver loses many of its vital functions.
LiSyM-Pillar II wants to know more about which factors promote fibrosis and the conditions under which fibrosis becomes irreversible How can fibrosis be diagnosed as early as possible? Researchers in the pillar are also
This generic project is intended to be a forum for all LiSyM partner and external stakeholders interested in participating in the BMBF initiative LiSyM-Krebs.
Organisms: Not specified
Day-to-day science within the LiSyM is overseen and directed by the the LiSyM Scientific Leadership Team. This coordination team comprises the pillar coordinators and additional LiSyM members, and ensures smooth interaction between multi-skilled groups, often working in different institutions and across significant distances within Germany.
Date Published: 29th Nov 2017
Publication Type: Not specified